Updates are available Erratum dated 2016-04-14
Click to view Erratum: https://doi.org/10.1038/eye.2016.16
Updates are available Erratum dated 2015-12-10
Click to view Erratum: https://doi.org/10.1038/eye.2015.237
-
Authors
Sivaprasad, S
,
Amoaku, W M
Hykin, P
- License Information
-
More Information
Article History
First Online: 28 August 2015
Change Date: 10 December 2015
Change Type: Correction
Change Details: This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue.
Competing interests
: SS has participated in Advisory Boards, and received educational travel grants and speaker fees from Bayer, Novartis, Allergan, and Roche. Her institution has received research grant funding from Allergan, Bayer, Novartis, and Roche. WMA has provided consultancy services to Alcon, Alimera, Allergan, Bayer, Novartis, and Thrombogenics. He has received travel grants from Alimera, Allergan, Bayer, and Novartis, and honoraria for lectures from Allergan and Novartis. He has participated in clinical trials for which his institution has received funding from Allergan, Novartis, and Pfizer. His institution has further received research grants from Allergan and Novartis for nonclinical studies, and CentreVue (Italy) for clinical studies. PH has participated in Advisory Boards, and received educational travel grants from Bayer, Novartis and Allergan. His institution has received research grant funding from Allergan, Bayer, and Novartis.
Free to read: This content has been made available to all.
